1. Home
  2. CDTX vs MVST Comparison

CDTX vs MVST Comparison

Compare CDTX & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDTX
  • MVST
  • Stock Information
  • Founded
  • CDTX 2012
  • MVST 2006
  • Country
  • CDTX United States
  • MVST United States
  • Employees
  • CDTX N/A
  • MVST N/A
  • Industry
  • CDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • MVST Industrial Machinery/Components
  • Sector
  • CDTX Health Care
  • MVST Miscellaneous
  • Exchange
  • CDTX Nasdaq
  • MVST Nasdaq
  • Market Cap
  • CDTX 1.4B
  • MVST 1.3B
  • IPO Year
  • CDTX 2015
  • MVST N/A
  • Fundamental
  • Price
  • CDTX $66.37
  • MVST $2.71
  • Analyst Decision
  • CDTX Strong Buy
  • MVST Strong Buy
  • Analyst Count
  • CDTX 11
  • MVST 1
  • Target Price
  • CDTX $57.00
  • MVST $6.00
  • AVG Volume (30 Days)
  • CDTX 427.5K
  • MVST 8.3M
  • Earning Date
  • CDTX 08-07-2025
  • MVST 08-11-2025
  • Dividend Yield
  • CDTX N/A
  • MVST N/A
  • EPS Growth
  • CDTX N/A
  • MVST N/A
  • EPS
  • CDTX N/A
  • MVST N/A
  • Revenue
  • CDTX N/A
  • MVST $422,605,000.00
  • Revenue This Year
  • CDTX N/A
  • MVST $26.08
  • Revenue Next Year
  • CDTX N/A
  • MVST $29.71
  • P/E Ratio
  • CDTX N/A
  • MVST N/A
  • Revenue Growth
  • CDTX N/A
  • MVST 20.84
  • 52 Week Low
  • CDTX $10.14
  • MVST $0.15
  • 52 Week High
  • CDTX $69.36
  • MVST $4.72
  • Technical
  • Relative Strength Index (RSI)
  • CDTX 65.51
  • MVST 43.41
  • Support Level
  • CDTX $59.80
  • MVST $2.44
  • Resistance Level
  • CDTX $69.36
  • MVST $2.70
  • Average True Range (ATR)
  • CDTX 3.83
  • MVST 0.25
  • MACD
  • CDTX -0.38
  • MVST 0.00
  • Stochastic Oscillator
  • CDTX 76.70
  • MVST 54.72

About CDTX Cidara Therapeutics Inc.

Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

About MVST Microvast Holdings Inc.

Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.

Share on Social Networks: